Citations (41)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Xiuli Yuan, Uet Yu, Senmin Chen, Huanli Xu, Meng Yi, Xianping Jiang, Jianming Song, Xiaowen Chen, Shiyang Chen, Zhenhu Lin, Changgang Li, Feiqiu Wen & Sixi Liu. (2021) Case Report: Myeloid Sarcoma Development During Treatment for B Cell Lymphoblastic Lymphoma in a Boy with KRAS/NRAS Gene Mutations. OncoTargets and Therapy 14, pages 347-353.
Read now
Read now
Robert Nakayama, Tomoaki Mori, Yusuke Okita, Yutaka Shiraishi & Makoto Endo. (2020) A multidisciplinary approach to soft-tissue sarcoma of the extremities. Expert Review of Anticancer Therapy 20:10, pages 893-900.
Read now
Read now
Samuele Renzi, Karin Langenberg-Ververgaert, Fabio Fuligni, Anne Louise Ryan, Scott Davidson, Nathaniel Anderson, Reid Hayes, Sevan Hopyan, Justin T. Gerstle, Mary Shago, Rose Chami, David Malkin, Adam Shlien, Anita Villani & Abha A. Gupta. (2018) Aggressive embryonal rhabdomyosarcoma in a 3-month-old boy: A clinical and molecular analysis. Pediatric Hematology and Oncology 35:7-8, pages 407-414.
Read now
Read now
Articles from other publishers (38)
Mehran Radak, Nakisa Ghamari & Hossein Fallahi. (2024) Identification of common factors among fibrosarcoma, rhabdomyosarcoma, and osteosarcoma by network analysis. Biosystems 235, pages 105093.
Crossref
Crossref
Abbas Agaimy & Alessandro Franchi. (2023) Spezielle mesenchymale Tumoren der Kopf-Hals-Region: Neues aus der WHO 2022Special mesenchymal neoplasms of the head and neck: Update from the 2022 WHO. Die Pathologie 44:4, pages 250-258.
Crossref
Crossref
Michela Asperti, Luca Cantamessa, Magdalena Gryzik, Mattia Bugatti, Silvia Codenotti, Andrea Denardo, William Vermi, Alessandro Fanzani & Maura Poli. (2023) The modulation of iron metabolism affects the Rhabdomyosarcoma tumor growth in vitro and in vivo. Clinical and Experimental Medicine.
Crossref
Crossref
Michael Frumovitz & Preetha Ramalingam. 2023. Diagnosis and Treatment of Rare Gynecologic Cancers. Diagnosis and Treatment of Rare Gynecologic Cancers
253
263
.
S. Deneuve, A. Guyennon, A. Dufresnes, L. Claude & M. Julieron. (2022) Sarcomi della testa e del collo. EMC - Otorinolaringoiatria 21:4, pages 1-27.
Crossref
Crossref
S. Deneuve, A. Guyennon, A. Dufresnes, L. Claude & M. Julieron. (2022) Sarcomas de cabeza y cuello. EMC - Otorrinolaringología 51:4, pages 1-28.
Crossref
Crossref
Abbas Agaimy, Josephine K. Dermawan, Iona Leong, Robert Stoehr, David Swanson, Ilan Weinreb, Lingxin Zhang, Cristina R. Antonescu & Brendan C. Dickson. (2022)
Recurrent
VGLL3
fusions define a distinctive subset of spindle cell rhabdomyosarcoma with an indolent clinical course and striking predilection for the head and neck
. Genes, Chromosomes and Cancer 61:12, pages 701-709.
Crossref
Crossref
Assil Fahs, Nader Hussein, Hasan Zalzali, Farah Ramadan, Farah Ghamloush, Hani Tamim, Mahmoud El Homsi, Bassam Badran, Fouad Boulos, Ayman Tawil, Sandra E. Ghayad & Raya Saab. (2022) CD147 Promotes Tumorigenesis via Exosome-Mediated Signaling in Rhabdomyosarcoma. Cells 11:15, pages 2267.
Crossref
Crossref
Jocelyn Y. Hsu, Nathan D. Seligson, John L. Hays, Wayne O. Miles & James L. Chen. (2022) Clinical Utility of CDK4/6 Inhibitors in Sarcoma: Successes and Future Challenges. JCO Precision Oncology:6.
Crossref
Crossref
Marius Winkler, Juliane Friedrich, Cathinka Boedicker & Nadezda Dolgikh. (2022) Co-targeting MCL-1 and ERK1/2 kinase induces mitochondrial apoptosis in rhabdomyosarcoma cells. Translational Oncology 16, pages 101313.
Crossref
Crossref
Wen-I Chang, Claire Lin, Nicholas Liguori, Joshua N. Honeyman, Bradley DeNardo & Wafik El-Deiry. (2022) Molecular Targets for Novel Therapeutics in Pediatric Fusion-Positive Non-CNS Solid Tumors. Frontiers in Pharmacology 12.
Crossref
Crossref
Ourania Parra, Ravina Thuraisingam, Michael L. Baker, Darcy A. Kerr & Konstantinos Linos. (2021) Adding Perplexity to Rarity: Diffuse S100-Protein and SOX10 Expression in a Molecularly Confirmed PAX7-Positive Primary Cutaneous Ewing Sarcoma. The American Journal of Dermatopathology 43:12, pages 984-989.
Crossref
Crossref
Daniela Di Carlo, Cyrus Chargari, Jean‐Yves Scoazec, Sophie Cotteret, Arthur Felix, Salma Moalla, Stephane Temam & Véronique Minard‐Colin. (2021) PAX3‐NCOA1 alveolar rhabdomyosarcoma of the tongue: A rare entity with challenging diagnosis and management. Pediatric Blood & Cancer.
Crossref
Crossref
Samuele Renzi, Noelle Cullinan, Sarah Cohen‐Gogo, Karin Langenberg‐Ververgaert, Orli Michaeli, Jalila Alkendi, Nisha Kanwar, Winnie Lo, Anita Villani, Adam Shlien, David Malkin, Anne L. Ryan, Bailey Gallinger, Katrina Ingley, Sevan Hopyan, Abha Gupta & Rose Chami. (2021) Non‐rhabdomyosarcoma soft tissue sarcomas diagnosed in patients at a young age. An overview of clinical, pathological, and molecular findings. Pediatric Blood & Cancer 68:8.
Crossref
Crossref
Raphael L. Yechieli, Henry C. Mandeville, Susan M. Hiniker, Valerie Bernier‐Chastagner, Susan McGovern, Giovanni Scarzello, Suzanne Wolden, Alison Cameron, John Breneman, Raquel Davila Fajardo & Sarah S. Donaldson. (2021) Rhabdomyosarcoma. Pediatric Blood & Cancer 68:S2.
Crossref
Crossref
Christine M. Heske, Yueh‐Yun Chi, Rajkumar Venkatramani, Minjie Li, Michael A. Arnold, Roshni Dasgupta, Susan M. Hiniker, Douglas S. Hawkins & Leo Mascarenhas. (2020)
Survival outcomes of patients with localized
FOXO1
fusion‐positive rhabdomyosarcoma treated on recent clinical trials: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group
. Cancer 127:6, pages 946-956.
Crossref
Crossref
Shahzadi ReshamDr.Dr., Muhammad Rafie RazaDr.Dr., Bilal Mazhar Qureshi, Arjumand Rizvi, Muhammad Shamvil AshrafDr.Dr. & Sadaf AltafDr.Dr.. (2021) Prognostic factors and their influence on therapeutic outcomes in children and adolescents with parameningeal rhabdomyosarcoma: A multicenter study from Pakistan. Pediatric Hematology Oncology Journal 6:1, pages 6-11.
Crossref
Crossref
Manasa Dondapati, Jonathan Vincent M. Reyes, Saad Ahmad, Aaron S. Stern & Joseph J. Lieber. (2021) Rare Adult Subtype of Rhabdomyosarcoma, a Common Childhood Soft Tissue Carcinoma. Journal of Investigative Medicine High Impact Case Reports 9, pages 232470962110422.
Crossref
Crossref
Xin Li, Jingwen Zhang, Min Zhang, Xianghua Qi, Shiyuan Wang & Jing Teng. (2021) Construction and comprehensive analysis of a competitive endogenous RNA network to reveal potential biomarkers for the malignant differentiation of glioma. Medicine 100:39, pages e27248.
Crossref
Crossref
Tatyana Milman, Cristiane M. Ida, Paul J.L. Zhang & Ralph C. EagleJr.Jr.. (2021) Gene Fusions in Ocular Adnexal Tumors. American Journal of Ophthalmology 221, pages 211-225.
Crossref
Crossref
Fiona Roberts & Chee Koon ThumFiona Roberts & Chee Koon Thum. 2021. Lee's Ophthalmic Histopathology. Lee's Ophthalmic Histopathology
389
421
.
Nobuhiko Sugito, Kazuki Heishima, Yuko Ito & Yukihiro Akao. (2020) Synthetic MIR143-3p Suppresses Cell Growth in Rhabdomyosarcoma Cells by Interrupting RAS Pathways Including PAX3–FOXO1. Cancers 12:11, pages 3312.
Crossref
Crossref
Oliver Uckunkaya, Peter Nöllke, Erika Hallmen, Cornelia Becker, Sabine Stegmaier, Monika Sparber-Sauer, Christian Vokuhl, Ewa Koscielniak & Simone Hettmer. (2020) Patterns of Prior and Subsequent Neoplasms in Children and Adolescents With Soft Tissue Sarcomas. Journal of Pediatric Hematology/Oncology 42:5, pages e265-e270.
Crossref
Crossref
Nil A. Schubert, Caitlin D. Lowery, Guillaume Bergthold, Jan Koster, Thomas F. Eleveld, Ana Rodríguez, David T.W. Jones, Gilles Vassal, Louis F. Stancato, Stefan M. Pfister, Hubert N. Caron & Jan J. Molenaar. (2020) Systematic target actionability reviews of preclinical proof-of-concept papers to match targeted drugs to paediatric cancers. European Journal of Cancer 130, pages 168-181.
Crossref
Crossref
Jessica Gartrell & Alberto Pappo. (2020) Recent advances in understanding and managing pediatric rhabdomyosarcoma. F1000Research 9, pages 685.
Crossref
Crossref
Emily A. Goebel, Silvia Hernandez Bonilla, Fei Dong, Brendan C. Dickson, Lien N. Hoang, David Hardisson, Maribel D. Lacambra, Fang-I Lu, Christopher D.M. Fletcher, Christopher P. Crum, Cristina R. Antonescu, Marisa R. Nucci & David L. Kolin. (2020) Uterine Tumor Resembling Ovarian Sex Cord Tumor (UTROSCT). American Journal of Surgical Pathology 44:1, pages 30-42.
Crossref
Crossref
Qianru Li, Liang Zhang, Jinfang Jiang, Yangyang Zhang, Xiaomeng Wang, Qiaochu Zhang, Yang Wang, Chunxia Liu & Feng Li. (2019) CDK1 and CCNB1 as potential diagnostic markers of rhabdomyosarcoma: validation following bioinformatics analysis. BMC Medical Genomics 12:1.
Crossref
Crossref
Senfen Wang, Ping Li, Jianhong Li, Jianzhong Liu, Xianping Jiang & Weibin Zeng. (2019) A case of congenital rhabdomyosarcoma. Pediatric Dermatology 36:5, pages 747-749.
Crossref
Crossref
Markku Miettinen, Anna Felisiak-Golabek, Alejandro Luiña Contreras, John Glod, Rosandra N. Kaplan, Jonathan Keith Killian & Jerzy Lasota. (2019) New fusion sarcomas: histopathology and clinical significance of selected entities. Human Pathology 86, pages 57-65.
Crossref
Crossref
Jennifer A. PerryBo Kyung Alex SeongKimberly Stegmaier. (2019) Biology and Therapy of Dominant Fusion Oncoproteins Involving Transcription Factor and Chromatin Regulators in Sarcomas. Annual Review of Cancer Biology 3:1, pages 299-321.
Crossref
Crossref
Stephen X. Skapek, Andrea Ferrari, Abha A. Gupta, Philip J. Lupo, Erin Butler, Janet Shipley, Frederic G. Barr & Douglas S. Hawkins. (2019) Rhabdomyosarcoma. Nature Reviews Disease Primers 5:1.
Crossref
Crossref
Jun Fan & Christine A. Iacobuzio-Donahue. 2019. Autopsy in the 21st Century. Autopsy in the 21st Century
151
166
.
Jonathan N Levenson, Kathleen A Regan, Jaya R Asirvatham & Siva SR Iyer. (2018) Vision loss secondary to orbital extension of rhabdomyosarcoma in an adult. Clinical & Experimental Ophthalmology 46:7, pages 831-833.
Crossref
Crossref
Ethan B. Ludmir, Arnold C. Paulino, David R. Grosshans, Mary Frances McAleer, Susan L. McGovern, Winston W. Huh, M. Fatih Okcu, Leslie M. Harrell & Anita Mahajan. (2018) Regional Nodal Control for Head and Neck Alveolar Rhabdomyosarcoma. International Journal of Radiation Oncology*Biology*Physics 101:1, pages 169-176.
Crossref
Crossref
F. Roberts & E.M. MacDuff. (2018) An update on mesenchymal tumours of the orbit with an emphasis on the value of molecular/cytogenetic testing. Saudi Journal of Ophthalmology 32:1, pages 3-12.
Crossref
Crossref
Nadezda Dolgikh & Simone Fulda. (2017) Rhabdomyosarcoma cells are susceptible to cell death by LDK378 alone or in combination with sorafenib independently of anaplastic lymphoma kinase status. Anti-Cancer Drugs 28:10, pages 1118-1125.
Crossref
Crossref
Penghui Yan, Zongqiang Huang & Junbo Zhu. (2017) Matrine inhibits cell proliferation and induces apoptosis of human rhabdomyosarcoma cells via downregulation of the extracellular signal-regulated kinase pathway. Oncology Letters 14:3, pages 3148-3154.
Crossref
Crossref
Alexander J. Hron & Atsushi Asakura. (2017) An Examination of the Role of Transcriptional and Posttranscriptional Regulation in Rhabdomyosarcoma. Stem Cells International 2017, pages 1-10.
Crossref
Crossref